MedPath

HEXACATH FRANCE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Comparative Phase IV Study: Efficacy And Safety of TiTAN2 Versus COBALT-CHROME Stents- EVIDENCEII

Phase 4
Conditions
Silent Myocardial Infarction
Stable Angina
Acute Coronary Syndrome
First Posted Date
2013-08-07
Last Posted Date
2014-01-08
Lead Sponsor
Hexacath, France
Target Recruit Count
1350
Registration Number
NCT01918150
Locations
🇫🇷

Clinique Claude Bernard, Albi, France

🇫🇷

Clinique de l'Europe, Amiens, France

🇫🇷

Hôpital Sud, Amiens, France

and more 39 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.